{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:05:54Z","timestamp":1774973154175,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level public health technical personnel construction project","award":["2022-3-036"],"award-info":[{"award-number":["2022-3-036"]}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals\u2019 Ascent Plan","doi-asserted-by":"crossref","award":["DFL20191802"],"award-info":[{"award-number":["DFL20191802"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX202126"],"award-info":[{"award-number":["ZYLX202126"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-26699-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:15:15Z","timestamp":1771938915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences between different antiretroviral therapy regimens switching patterns among people living with HIV"],"prefix":"10.1186","volume":"26","author":[{"given":"Hanxi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhennan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiu","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"26699_CR1","unstructured":"European AIDS. Clinical Society. European Guidelines for Clinical Management and Treatment of HIV-1-Infected Adults in Europe, version 9.1. 2018. http:\/\/www.eacsociety.org\/fles\/2018_guidelines-9.1-english.pdf"},{"key":"26699_CR2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services.\u00a02024.\u00a0https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new."},{"key":"26699_CR3","unstructured":"HIV\/AIDS Hepatitis C, Group. Chinese Association of Infectious Diseases, Chinese Center for Disease Control and Prevention. Chinese AIDS diagnosis and treatment guidelines. (Version 2024). Chinese Journal of Infectious Diseases,42: epub. https:\/\/doi.org\/10.3760\/cma.j.cn311365-20240328-00081. [in Chinese]. https:\/\/rs.yiigle.com\/cmaid\/1501644. (2024)."},{"key":"26699_CR4","unstructured":"UNAIDS data. 2023. 2024.\u00a0https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/2023_unaids_data."},{"issue":"9939","key":"26699_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/s0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet Jul 19. 2014;384(9939):258\u201371. https:\/\/doi.org\/10.1016\/s0140-6736(14)60164-1.","journal-title":"Lancet Jul 19"},{"issue":"12","key":"26699_CR6","first-page":"1106","volume":"60","author":"AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association","year":"2021","unstructured":"AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association. Chinese center for disease control and Prevention. Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition). Zhonghua Nei Ke Za Zhi. 2021;60(12):1106\u201328.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"26699_CR7","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1038\/s41467-023-41051-w","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Wu G, Ma P, Wang R, Li L, Chen Y, et al. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China. Nat Commun. 2023;14(1):5334.","journal-title":"Nat Commun"},{"key":"26699_CR8","doi-asserted-by":"publisher","unstructured":"Lan Y, Li L, Xin R, Ling X, Deng X, Li J et al. Drug resistance to integrase Strand-Transfer inhibitors among HIV-1-Infected adults in Guangdong, China. Pathogens. 2022;11(11):1321.\u00a0https:\/\/doi.org\/10.3390\/pathogens11111321.","DOI":"10.3390\/pathogens11111321"},{"issue":"6","key":"26699_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s15010-021-01668-9","volume":"49","author":"Z Yang","year":"2021","unstructured":"Yang Z, Yang X, Deng X, Wei S, Liu J, Ma J, et al. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018\u20132020). Infection. 2021;49(6):1195\u2013202.","journal-title":"Infection"},{"key":"26699_CR10","doi-asserted-by":"publisher","first-page":"975397","DOI":"10.3389\/fgene.2022.975397","volume":"13","author":"W Fan","year":"2022","unstructured":"Fan W, Wang X, Zhang Y, Meng J, Su M, Yang X, et al. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China. Front Genet. 2022;13:975397.","journal-title":"Front Genet"},{"issue":"10","key":"26699_CR11","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/S2352-3018(17)30109-1","volume":"4","author":"S Kanters","year":"2017","unstructured":"Kanters S, et al. Comparative efficacy and safety of second-line antiretroviral therapy for the treatment of HIV\/AIDS: a systematic review and network meta-analysis. Lancet HIV. 2017;4(10):e433\u201341.","journal-title":"Lancet HIV"},{"issue":"12","key":"26699_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/cid\/cix1108","volume":"66","author":"AJ Stockdale","year":"2018","unstructured":"Stockdale AJ, et al. Efectiveness of protease inhibitor\/nucleos (t) Ide reverse transcriptase inhibitor\u2013based second-line antiretroviral therapy for the treatment of human immunodefciency virus type 1 infection in sub-Saharan africa: a systematic review and meta-analysis. Clin Infect Dis. 2018;66(12):1846\u201357.","journal-title":"Clin Infect Dis"},{"issue":"13","key":"26699_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1177\/09564624231181156","volume":"34","author":"SL Valderrama-Beltr\u00e1n","year":"2023","unstructured":"Valderrama-Beltr\u00e1n SL, Mart\u00ednez-Vernaza S, Correa-Forero SV, et al. Reasons for antiretroviral switching in colombia: A retrospective cohort study. Int J STD AIDS. 2023;34(13):921\u201331. https:\/\/doi.org\/10.1177\/09564624231181156.","journal-title":"Int J STD AIDS"},{"key":"26699_CR14","doi-asserted-by":"publisher","unstructured":"Teeraananchai S et al. Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia. Journal of the International AIDS Society vol. 25,8(2022):e25989. https:\/\/doi.org\/10.1002\/jia2.25989","DOI":"10.1002\/jia2.25989"},{"issue":"1","key":"26699_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12981-022-00453-4","volume":"19","author":"A Kabarambi","year":"2022","unstructured":"Kabarambi A, Balinda S, Abaasa A, Cogill D, Orrell C. Determinants and reasons for switching anti-retroviral regimen among HIV-infected youth in a large Township of South Africa (2002\u20132019). AIDS Res Therapy. 2022;19(1):32. https:\/\/doi.org\/10.1186\/s12981-022-00453-4.","journal-title":"AIDS Res Therapy"},{"issue":"1","key":"26699_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","volume":"17","author":"W Cao","year":"2020","unstructured":"Cao W, et al. Optimizing treatment for adults with HIV\/AIDS in china: successes over two decades and remaining challenges. Curr HIV\/AIDS Rep Vol. 2020;17(1):26\u201334. https:\/\/doi.org\/10.1007\/s11904-019-00478-x.","journal-title":"Curr HIV\/AIDS Rep Vol"},{"issue":"5","key":"26699_CR17","doi-asserted-by":"publisher","first-page":"e63596","DOI":"10.1371\/journal.pone.0063596","volume":"8","author":"C Njuguna","year":"2013","unstructured":"Njuguna C, et al. Rates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of Tenofovir. PLoS ONE. 2013;8(5):e63596.","journal-title":"PLoS ONE"},{"issue":"9","key":"26699_CR18","doi-asserted-by":"publisher","first-page":"e1003325","DOI":"10.1371\/journal.pmed.1003325","volume":"17","author":"A Amstutz","year":"2020","unstructured":"Amstutz A, Nsakala BL, Vanobberghen F, et al. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: an open-label randomized controlled trial in Lesotho. PLoS Med. 2020;17(9):e1003325. https:\/\/doi.org\/10.1371\/journal.pmed.1003325.","journal-title":"PLoS Med"},{"issue":"8","key":"26699_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/tmi.13595","volume":"26","author":"AE Njom-Nlend","year":"2021","unstructured":"Njom-Nlend AE, Efouba N, Sandie B, A., Fokam J. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon. Trop Med Int Health: TM IH. 2021;26(8):927\u201335. https:\/\/doi.org\/10.1111\/tmi.13595.","journal-title":"Trop Med Int Health: TM IH"},{"issue":"1","key":"26699_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/09540121.2010.498867","volume":"23","author":"J Landier","year":"2011","unstructured":"Landier J, Akonde A, Pizzocolo C, et al. Switch to second-line ART in West African routine care: incidence and reasons for switching. AIDS Care. 2011;23(1):75\u20138. https:\/\/doi.org\/10.1080\/09540121.2010.498867.","journal-title":"AIDS Care"},{"issue":"3","key":"26699_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3760\/cma.j.issn.0254-6450.2020.03.024","volume":"41","author":"HX Zhang","year":"2020","unstructured":"Zhang HX, Han MJ, Zhou Y, Xiu XF, Xu F, Wang L. Zhonghua Liuxingbingxue Zazhi. 2020;41(3):406\u201311. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2020.03.024. [Article in Chinese].","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"26699_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2147\/RMHP.S459173","volume":"17","author":"Z Xie","year":"2024","unstructured":"Xie Z, Duan Z. Evolving challenges in the implementation of china\u2019s four frees and one care policy for HIV\/AIDS. Risk Manage Healthc Policy. 2024;17:1315\u201321. https:\/\/doi.org\/10.2147\/RMHP.S459173.","journal-title":"Risk Manage Healthc Policy"},{"key":"26699_CR23","unstructured":"National Center for AIDS\/STD Control and Prevention, China CDC. National Manual of Free HIV Antiviral Drug Treatment (5th Edition). People\u2019s Medical Publishing House. 2023.06. ISBN: 9787117348430."},{"issue":"2","key":"26699_CR24","doi-asserted-by":"publisher","first-page":"e25034","DOI":"10.1002\/jia2.25034","volume":"21","author":"V Mehraj","year":"2018","unstructured":"Mehraj V, Cox J, Lebouch\u00e9 B, Costiniuk C, Cao W, Li T, Ponte R, Thomas R, Szabo J, Baril JG, Trottier B, C\u00f4t\u00e9 P, LeBlanc R, Bruneau J, Tremblay C, Routy JP, Montreal Primary HIV-Infection Study Group. Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, canada: 1996 to 2015. J Int AIDS Soc. 2018;21(2):e25034. https:\/\/doi.org\/10.1002\/jia2.25034.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"26699_CR25","doi-asserted-by":"publisher","first-page":"e0255108","DOI":"10.1371\/journal.pone.0255108","volume":"16","author":"Y Sun","year":"2021","unstructured":"Sun Y, Li G, Lu H. Awareness and use of nonoccupational HIV post-exposure prophylaxis and factors associated with awareness among MSM in Beijing, China. PLoS ONE. 2021;16(8):e0255108. https:\/\/doi.org\/10.1371\/journal.pone.0255108.","journal-title":"PLoS ONE"},{"issue":"06","key":"26699_CR26","first-page":"282","volume":"12","author":"J Wang","year":"2018","unstructured":"Wang J, He S, Li Y, Lu H. Analysis of epidemiological characteristics of HIV\/AIDS in Beijing, 2017. Capital J Public Health. 2018;12(06):282\u20134.","journal-title":"Capital J Public Health"},{"issue":"8","key":"26699_CR27","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s10461-018-2175-5","volume":"22","author":"BA Koblin","year":"2018","unstructured":"Koblin BA, Usher D, Nandi V, Tieu HV, Bravo E, Lucy D, et al. Post-exposure Prophylaxis Awareness, Knowledge, Access and Use Among Three Populations in New York City. AIDS Behav. 2018;22(8):2016\u201317.","journal-title":"AIDS Behav"},{"issue":"5","key":"26699_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/QAI.0b013e3182a7ef21","volume":"64","author":"G Armstrong","year":"2013","unstructured":"Armstrong G, Jorm AF, Samson L, Joubert L, Nuken A, Singh S, et al. Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi, India. J Acquir Immune Defic Syndr. 2013;64(5):502\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"26699_CR29","doi-asserted-by":"publisher","unstructured":"Kissi PS. Impact of social media health promotion on HIV\/AIDS stigma reduction: the role of multi-language campaign and emotional empathy. AIDS Care 37,11 (2025): 1959\u201377. https:\/\/doi.org\/10.1080\/09540121.2025.2562460","DOI":"10.1080\/09540121.2025.2562460"},{"issue":"9","key":"26699_CR30","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1080\/09540121.2025.2534121","volume":"37","author":"X Bilon","year":"2025","unstructured":"Bilon X, Javines. Examining the digital connections: comprehensive HIV knowledge, awareness of antiretroviral therapy, and digital media use among adolescents and young adults in a middle-income country. AIDS Care Vol. 2025;37(9):1576\u201386. https:\/\/doi.org\/10.1080\/09540121.2025.2534121.","journal-title":"AIDS Care Vol"},{"issue":"14","key":"26699_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/QAD.0b013e32832e05b2","volume":"23","author":"O Keiser","year":"2009","unstructured":"Keiser O, et al. Switching to second-line antiretroviral therapy in resource limited settings: comparison of programmes with and without viral load monitoring. AIDS. 2009;23(14):1867.","journal-title":"AIDS"},{"key":"26699_CR32","doi-asserted-by":"publisher","unstructured":"Elzi L, Marzolini C, Furrer H, et al. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine.\u00a0170(1):57\u201365.\u00a0https:\/\/doi.org\/10.1001\/archinternmed.2009.432.","DOI":"10.1001\/archinternmed.2009.432"},{"key":"26699_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2334-12-296","volume":"12","author":"MC Prosperi","year":"2012","unstructured":"Prosperi MC, et al. Predictors of frst-line antiretroviral therapy discontinuation due to drug-related adverse events in HIVinfected patients: A retrospective cohort study. BMC Infect Dis. 2012;12:296. https:\/\/doi.org\/10.1186\/1471-2334-12-296.","journal-title":"BMC Infect Dis"},{"key":"26699_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/QAD.0b013e32835cb997","volume":"27","author":"S Abgrall","year":"2013","unstructured":"Abgrall S, Antiretroviral Terapy Cohort Collaboration (ART-CC), et al. Durability of Frst ART regimen and risk factors for modifcation, interruption or death in HIV-positive patients starting ART in Europe and North America 2002\u20132009. AIDS. 2013;27:803\u201313.","journal-title":"AIDS"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26699-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:00:00Z","timestamp":1774965600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26699-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26699"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26699-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee and Internal Review Boards of Beijing Ditan Hospital, Capital Medical University (NO. DTEC-KY2021-022-03). And followed the guidelines formulated by Beijing Ditan Hospital, Capital Medical University Ethics Committee. All participants were obtained oral informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1067"}}